Profund Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Sell |
9,638
-1,618
| -14% | -$37.1K | 0.01% | 844 |
|
|
2025
Q1 | $326K | Buy |
11,256
+3,336
| +42% | +$96.7K | 0.01% | 633 |
|
|
2024
Q4 | $294K | Sell |
7,920
-36
| -0.5% | -$1.34K | 0.01% | 775 |
|
|
2024
Q3 | $386K | Sell |
7,956
-534
| -6% | -$25.9K | 0.01% | 658 |
|
|
2024
Q2 | $340K | Sell |
8,490
-168
| -2% | -$6.72K | 0.01% | 650 |
|
|
2024
Q1 | $380K | Buy |
8,658
+1,763
| +26% | +$77.4K | 0.01% | 712 |
|
|
2023
Q4 | $426K | Sell |
6,895
-2,455
| -26% | -$152K | 0.02% | 598 |
|
|
2023
Q3 | $430K | Buy |
9,350
+3,132
| +50% | +$144K | 0.02% | 504 |
|
|
2023
Q2 | $357K | Buy |
+6,218
| New | +$357K | 0.02% | 629 |
|
|
2022
Q2 | – | Sell |
-5,963
| Closed | -$214K | – | 1035 |
|
|
2022
Q1 | $214K | Buy |
+5,963
| New | +$214K | 0.01% | 1218 |
|
|
2019
Q1 | – | Sell |
-13,312
| Closed | -$265K | – | 1213 |
|
|
2018
Q4 | $265K | Sell |
13,312
-6,059
| -31% | -$121K | 0.02% | 845 |
|
|
2018
Q3 | $373K | Buy |
+19,371
| New | +$373K | 0.01% | 1030 |
|